BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24698651)

  • 1. From non-pharmacological treatments for post-traumatic stress disorder to novel therapeutic targets.
    Hendriksen H; Olivier B; Oosting RS
    Eur J Pharmacol; 2014 Jun; 732():139-58. PubMed ID: 24698651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of post-traumatic stress disorder and novel treatment targets.
    Aspesi D; Pinna G
    Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):130-150. PubMed ID: 30741728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary care treatment of post-traumatic stress disorder.
    Lange JT; Lange CL; Cabaltica RB
    Am Fam Physician; 2000 Sep; 62(5):1035-40, 1046. PubMed ID: 10997529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder.
    Watts BV; Schnurr PP; Mayo L; Young-Xu Y; Weeks WB; Friedman MJ
    J Clin Psychiatry; 2013 Jun; 74(6):e541-50. PubMed ID: 23842024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents (Review).
    Gillies D; Taylor F; Gray C; O'Brien L; D'Abrew N
    Evid Based Child Health; 2013 May; 8(3):1004-116. PubMed ID: 23877914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
    Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single prolonged stress: toward an animal model of posttraumatic stress disorder.
    Yamamoto S; Morinobu S; Takei S; Fuchikami M; Matsuki A; Yamawaki S; Liberzon I
    Depress Anxiety; 2009; 26(12):1110-7. PubMed ID: 19918929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Gulf War Syndrome twenty years on].
    Auxéméry Y
    Encephale; 2013 Oct; 39(5):332-8. PubMed ID: 23351934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-exposure and environmental enrichment reveal NPY-Y1 as a possible target for post-traumatic stress disorder.
    Hendriksen H; Bink DI; Daniels EG; Pandit R; Piriou C; Slieker R; Westphal KG; Olivier B; Oosting RS
    Neuropharmacology; 2012 Sep; 63(4):733-42. PubMed ID: 22659471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-traumatic stress disorders: diagnostic and therapeutic principles ].
    Schnyder U
    Praxis (Bern 1994); 2003 Feb; 92(8):337-43. PubMed ID: 12649966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTSD and stress sensitisation: a tale of brain and body Part 1: human studies.
    Stam R
    Neurosci Biobehav Rev; 2007; 31(4):530-57. PubMed ID: 17270271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].
    Yao SN; Cottraux J; Note I; De Mey-Guillard C; Mollard E; Ventureyra V
    Encephale; 2003; 29(3 Pt 1):232-8. PubMed ID: 12876547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-resistant posttraumatic stress disorder: strategies for intervention.
    Hamner MB; Robert S; Frueh BC
    CNS Spectr; 2004 Oct; 9(10):740-52. PubMed ID: 15448585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and treatment of post-traumatic stress disorder.
    Witt PH; Greenfield DP; Steinberg J
    N J Med; 1993 Jun; 90(6):464-7. PubMed ID: 8414203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drug development for post-traumatic stress disorder.
    Berlant J
    Curr Opin Investig Drugs; 2003 Jan; 4(1):37-41. PubMed ID: 12625026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effectiveness of tianeptine, clonidine and amitriptyline in blocking traumatic memory expression, anxiety and hypertension in an animal model of PTSD.
    Zoladz PR; Fleshner M; Diamond DM
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():1-16. PubMed ID: 23318688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigational drugs under development for the treatment of PTSD.
    Ragen BJ; Seidel J; Chollak C; Pietrzak RH; Neumeister A
    Expert Opin Investig Drugs; 2015 May; 24(5):659-72. PubMed ID: 25773140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone ameliorates post-traumatic stress disorder-like symptoms in modified stress re-stress model.
    Krishnamurthy S; Garabadu D; Joy KP
    Neuropharmacology; 2013 Dec; 75():62-77. PubMed ID: 23891637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological and pharmacologic treatment of youth with posttraumatic stress disorder: an evidence-based review.
    Keeshin BR; Strawn JR
    Child Adolesc Psychiatr Clin N Am; 2014 Apr; 23(2):399-411, x. PubMed ID: 24656587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.